SEARCH

SEARCH BY CITATION

References

  • Adams D. H., Hanson G. R. and Keefe K. A. (2001) Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102, 843851.
  • Albers D. S. and Sonsalla P. K. (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275, 11041114.
  • Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A. and Aloisi F. (2003) Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41, 290300.
  • Barrett T., Xie T., Piao Y. et al. (2001) A murine dopamine neuron-specific cDNA library and microarray: increased COXI expression during methamphetamine neurotoxicity. Neurobiol. Dis. 8, 822833.
  • Berry M. D. and Boulton A. A. (2000) Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J. Neurosci. Res. 60, 150154.
  • Bowyer J. F., Gough B., Slikker W. Jr, Lipe G. W., Newport G. D. and Holson R. R. (1993) Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44, 8798.
  • Bowyer J. F., Davies D. L., Schmued L., Broening H. W., Newport G. D., Slikker W. Jr and Holson R. R. (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268, 15711580.
  • Brown J. M., Hanson G. R. and Fleckenstein A. E. (2000) Methamphetamine rapidly decreases vesicular dopamine uptake. J. Neurochem. 74, 22212223.
  • Burrows K. B., Gudelsky G. and Yamamoto B. K. (2000) Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J. Pharmacol. 398, 1118.
  • Cadet J. L. and Brannock C. (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32, 117131.
  • Cadet J. L., Jayanthi S., McCoy M. T., Vawter M. and Ladenheim B. (2001) Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41, 4048.
  • Cadet J. L., McCoy M. T. and Ladenheim B. (2002) Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: Evidence from cDNA array analyses. Synapse 44, 211226.
  • Callahan B. T., Cord B. J., Yuan J., McCann U. D. and Ricaurte G. A. (2001) Inhibitors of Na+/H+ and Na+/Ca2+exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity. J. Neurochem. 77, 13481362.
  • Chesnokova V., Kariagina A. and Melmed S. (2002) Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Am. J. Physiol. Endocrinol. Metab. 282, E1110E1118.
  • Cubells J. F., Rayport S., Rajendran G. and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 22602271.
  • Davidson C., Gow A. J., Lee T. H. and Ellinwood E. H. (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36, 122.
  • Deng X., Wang Y., Chou J. and Cadet J. L. (2001) Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol Brain Res. 93, 6469.
  • Deng X., Jayanthi S., Ladenheim B., Krasnova I. N. and Cadet J. L. (2002) Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Mol. Pharmacol. 62, 9931000.
  • Devireddy L. R., Teodoro J. G., Richard F. A. and Green M. R. (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293, 829834.
  • Draghici S. (2002) Statistical intelligence: effective analysis of high-density microarray data. Drug Discov. Today 7, S55S63.
  • Du Y., Ma Z., Lin S. et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 1466914674.
  • Eisen M. B., Spellman P. T., Brown P. O. and Botstein D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 1486314868.
  • Fleckenstein A. E., Gibb J. W. and Hanson G. R. (2000) Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406, 113.
  • Flynn G., Maru S., Loughlin J., Romero I. A. and Male D. (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136, 8493.
  • Fukumura M., Cappon G. D., Pu C., Broening H. W. and Vorhees C. V. (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res. 806, 17.
  • Gibb J. W., Stone D. M., Johnson M. and Hanson G. R. (1989) Role of dopamine in the neurotoxicity induced by amphetamines and related designer drugs. NIDA Res. Monogr. 94, 161178.
  • Gibbons F. D. and Roth F. P. (2002) Judging the quality of gene expression-based clustering methods using gene annotation. Genome Res. 12, 15741581.
  • Grundemann D., Hahne C., Berkels R. and Schomig E. (2003) Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2). J. Pharmacol. Exp. Ther. 304, 810817.
  • Hanson G. R., Matsuda L. A. and Gibb J. W. (1987) Effects of cocaine on methamphetamine-induced neurochemical changes: characterization of cocaine as a monoamine uptake blocker. J. Pharmacol. Exp. Ther. 242, 507513.
  • Hartigan J. (1975) Clustering Algorithms. John Wiley & Sons, New York.
  • Hastie T., Tibshirani R. and Walther G. (2001) Estimating the number of data clusters via the Gap statistic. Journal of the Royal Statistical Society: Series B (Statist. Methodol.) 63, 411423.
  • Haughey H. M., Brown J. M., Wilkins D. G., Hanson G. R. and Fleckenstein A. E. (2000) Differential effects of methamphetamine on Na+/C-dependent transporters. Brain Res. 863, 5965.
  • He Y., Appel S. and Le W. (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909, 187193.
  • Heyer L. J., Kruglyak S. and Yooseph S. (1999) Exploring expression data: identification and analysis of coexpressed genes. Genome Res. 9, 11061115.
  • Imam S. Z., El-Yazal J., Newport G. D., Itzhak Y., Cadet J. L., Slikker W. Jr and Ali S. F. (2001) Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann. N. Y. Acad. Sci. 939, 366380.
  • Jayanthi S., Deng X., Bordelon M., McCoy M. T. and Cadet J. L. (2001) Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. Faseb J. 15, 17451752.
  • Kaufman L. and Rousseeuw P. J. (1990) Finding Groups in Data, an Introduction to Cluster Analysis. John Wiley & Sons, Brussels.
  • Kim S. H., Won S. J., Sohn S., Kwon H. J., Lee J. Y., Park J. H. and Gwag B. J. (2002) Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase. J. Cell Biol. 159, 821831.
  • Larsen K. E., Fon E. A., Hastings T. G., Edwards R. H. and Sulzer D. (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 22, 89518960.
  • LaVoie M. J. and Hastings T. G. (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 14841491.
  • Lee M. L., Kuo F. C., Whitmore G. A. and Sklar J. (2000) Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc. Natl Acad. Sci. USA 97, 98349839.
  • Mennicken F., Maki R., De Souza E. B. and Quirion R. (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20, 7378.
  • Miller D. B. and O'Callaghan J. P. (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 752760.
  • Miller D. B. and O'Callaghan J. P. (2003) Elevated environmental temperature and methamphetamine neurotoxicity. Environ. Res. 92, 4853.
  • Narita M., Aoki K., Takagi M., Yajima Y. and Suzuki T. (2003) Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119, 767775.
  • Nauta A. J., Bottazzi B., Mantovani A. et al. (2003) Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33, 465473.
  • Nixdorf W. L., Burrows K. B., Gudelsky G. A. and Yamamoto B. K. (2001) Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. J. Neurochem. 77, 647654.
  • O'Callaghan J. P. and Miller D. B. (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 741751.
  • Patel H. C., Boutin H. and Allan S. M. (2003) Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. Ann. N. Y. Acad. Sci. 992, 3947.
  • Petersen A. A., Larsen K. E., Behr G. G., Romero N., Przedborski S., Brundin P. and Sulzer D. (2001) Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res. Bull. 56, 331335.
  • Pu C. and Vorhees C. V. (1995) Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immuno-histochemical study. Synapse 19, 97104.
  • Ramanathan M., Weinstock-Guttman B., Nguyen L. T., Badgett D., Miller C., Patrick K., Brownscheidle C. and Jacobs L. (2001) In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116, 213219.
  • Rovere P., Peri G., Fazzini F. et al. (2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96, 43004306.
  • Ruprecht K., Kuhlmann T., Seif F., Hummel V., Kruse N., Bruck W. and Rieckmann P. (2001) Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J. Neuropathol. Exp. Neurol. 60, 10871098.
  • Ryckman C., Vandal K., Rouleau P., Talbot M. and Tessier P. A. (2003) Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170, 32333242.
  • Schmidt C. J. and Gibb J. W. (1985) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur. J. Pharmacol. 109, 7380.
  • Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R. and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539544.
  • Serafini B., Columba-Cabezas S., Di Rosa F. and Aloisi F. (2000) Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157, 19912002.
  • Stephans S. E., Whittingham T. S., Douglas A. J., Lust W. D. and Yamamoto B. K. (1998) Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J. Neurochem. 71, 613621.
  • Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E. S. and Golub T. R. (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl Acad. Sci. USA 96, 29072912.
  • Tikka T., Fiebich B. L., Goldsteins G., Keinanen R. and Koistinaho J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 25802588.
  • Tong Z., Wu X. and Kehrer J. P. (2003) Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem. J. 372, 203210.
  • Witke W., Li W., Kwiatkowski D. J. and Southwick F. S. (2001) Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J. Cell Biol. 154, 775784.
  • Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D. K., Ischiropoulos H. and Przedborski S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 17631771.
  • Xie T., Tong L., Barrett T., Yuan J., Hatzidimitriou G., McCann U. D., Becker K. G., Donovan D. M. and Ricaurte G. A. (2002) Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 22, 274283.
  • Yamamoto B. K. and Zhu W. (1998) The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp Ther 287, 107114.
  • Yamamoto B. K., Gudelsky G. A. and Stephans S. E. (1998) Amphetamine neurotoxicity: roles for dopamine, glutatamate, and oxidative stress, in Progress in HPLC-HPCE, Vol. 7 (QureshiG. A., ed.), pp. 223244. VSP, Bombay.
  • Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T. and Koistinaho J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad. Sci. USA 95, 1576915774.
  • Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P. H. and Koistinaho J. (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl Acad. Sci. USA 96, 1349613500.
  • Yui S., Nakatani Y. and Mikami M. (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26, 753760.